Emergent BioSolutions (EBS) Current Assets (2010 - 2026)
Emergent BioSolutions (EBS) posted quarterly Current Assets of $637.6 million for Q1 2026, down 9.79% year-over-year from $706.8 million in Q1 2025, and down 3.76% quarter-over-quarter from $662.5 million in Q4 2025.
Emergent BioSolutions (EBS) Current Assets (2010 - 2026) Analysis & Trends
Emergent BioSolutions' Current Assets history runs 17 years deep, the most recent figure standing at $637.6 million for Q1 2026.
- In Q1 2026, Current Assets fell 9.79% year-over-year to $637.6 million; the TTM figure through Mar 2026 stood at $637.6 million (down 9.79% YoY), while the FY2025 annual figure was $662.5 million, up 10.66% from the prior year.
- Current Assets for Q1 2026 stood at $637.6 million, down from $662.5 million in the prior quarter.
- The five-year high for Current Assets was $1.2 billion in Q1 2023, with the low at $598.7 million in Q4 2024.
- The 5-year median for Current Assets is $719.5 million (2025), against an average of $823.7 million.
- The sharpest annual moves came in 2024 and 2025: Current Assets tumbled 44.13% in 2024, then climbed 18.97% in 2025.
- Emergent BioSolutions' Current Assets stood at $1.2 billion in 2022, then plunged by 43.86% to $679.5 million in 2023, then fell by 11.89% to $598.7 million in 2024, then gained by 10.66% to $662.5 million in 2025, then fell by 3.76% to $637.6 million in 2026.
- Business Quant data shows EBS's Current Assets at $637.6 million in Q1 2026, $662.5 million in Q4 2025, and $786.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.22 Bn |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn | 666.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 666.00 Mn |
| Mar 31, 2026 | 637.60 Mn |
| Dec 31, 2025 | 662.50 Mn |
| Sep 30, 2025 | 786.90 Mn |
| Jun 30, 2025 | 719.50 Mn |
| Mar 31, 2025 | 706.80 Mn |
| Dec 31, 2024 | 598.70 Mn |
| Sep 30, 2024 | 661.40 Mn |
| Jun 30, 2024 | 654.50 Mn |
| Mar 31, 2024 | 682.40 Mn |
| Dec 31, 2023 | 679.50 Mn |
| Sep 30, 2023 | 720.80 Mn |
| Jun 30, 2023 | 777.70 Mn |
| Mar 31, 2023 | 1.22 Bn |
| Dec 31, 2022 | 1.21 Bn |
| Sep 30, 2022 | 1.10 Bn |
| Jun 30, 2022 | 1.08 Bn |
| Mar 31, 2022 | 1.10 Bn |
| Dec 31, 2021 | 1.27 Bn |
| Sep 30, 2021 | 1.11 Bn |